Precision Fermentation CDMO Services Market Size, Share, Growth and Forecast (2026 - 2036)

What is the precision fermentation CDMO services market forecast to be worth by 2036?

USD 0.6 billion in 2026 to USD 15.0 billion by 2036, at 38.0% CAGR.

• The precision fermentation CDMO services market was valued at USD 0.4 billion in 2025.
• Demand is expected to increase from USD 0.6 billion in 2026 to USD 15.0 billion by 2036.
• The market is forecast to record 38.0% CAGR during 2026 to 2036 as fermentation-based food ingredient brands outsource scale-up and downstream processing.

What are the defining numbers behind precision fermentation CDMO services growth?

USD 14.4 billion absolute opportunity by 2036, led by the United States and Denmark.

• Demand Drivers in the Market
  • Fermentation ingredient brands need food-grade capacity before products can leave pilot stage.
  • Food majors need outsourced production partners before testing animal-free dairy and functional proteins.
  • Startups need downstream processing support because purification often decides ingredient cost.
  • CDMOs need quality systems that meet food and regulatory expectations.
• Key Segments Analyzed
  • By Service Type: Food-Grade Contract Manufacturing is expected to hold 36.0% share in 2026 as commercial bioreactor access is the main bottleneck.
  • By Ingredient Type: Dairy Proteins lead because whey and beta-lactoglobulin are early precision-fermentation targets. The share is projected at 41.0% in 2026.
  • By Customer Type: Fermentation-Based Food and Ingredient Brands lead because most lack owned manufacturing assets. This customer type is likely to account for 46.0% share in 2026.
  • By Delivery Model: Capacity Reservation and Toll Manufacturing lead as brands need secured slots before launch. The model is projected to hold 39.0% share in 2026.
  • By End Use: Animal-Free Dairy Ingredients are expected to hold 37.0% share in 2026 since dairy proteins have high functionality and clear food applications.
  • By Geography: The United States is projected to record 42.2% CAGR through 2036 as commercial-scale food fermentation capacity comes online.
• Analyst Opinion at Fact.MR
  • Shambhu Nath Jha, Senior Analyst at Fact.MR, states, “Precision fermentation is entering a capacity-constrained phase. We see ingredient brands asking who can move them from pilot batches to reliable commercial production. Providers that combine food-grade fermentation and launch support will gain stronger access to the next generation of food ingredients.”
• Strategic Implications
  • Ingredient startups should secure manufacturing slots before commercial launch timelines are announced.
  • Food brands need CDMO partners that can support quality and regulatory documentation.
  • CDMOs should build downstream processing depth because purification drives final ingredient economics.
  • Capacity providers need flexible contracts that support both pilot batches and commercial volumes.

The market covers contract development and manufacturing services that help brands scale precision-fermented food ingredients such as dairy proteins and collagen without building their own bioreactors. Liberation Bioindustries says its Richmond, Indiana facility has 600,000 liters of precision fermentation capacity and a dedicated downstream process line. [1] This gives food and ingredient companies a commercial-scale service base.

The United States is projected to record 42.2% CAGR from 2026 to 2036 as Liberation Bioindustries brings commercial-scale capacity online. Denmark will gain from pilot-scale and strain-to-scale expertise. The country is expected to post 40.6% CAGR through 2036. Switzerland is likely to record 39.4% CAGR by 2036 as Planetary-style fermentation platforms support European ingredient brands. Belgium is forecast to advance at 37.8% CAGR as BioBrew uses AB InBev fermentation and downstream processing expertise. South Korea is set to record 36.7% CAGR as CJ CheilJedang’s fermentation base supports food and nutrition ingredient scale-up.

How does the precision fermentation CDMO services market break down by segment?

Food-Grade Contract Manufacturing leads at 36.0%; Dairy Proteins lead at 41.0%.

Which service type dominates?

Food-Grade Contract Manufacturing holds 36.0% share in 2026.

Food-Grade Contract Manufacturing is expected to hold 36.0% share in 2026 because commercial bioreactor access is the main bottleneck. The service covers production batches and quality documentation. Manufacturing leads because brands cannot commercialize ingredients without dependable capacity.

Which ingredient type dominates?

Dairy Proteins lead because they are early precision-fermentation targets.

Dairy Proteins lead because whey and beta-lactoglobulin can improve taste and nutrition in animal-free dairy products. These ingredients need consistent purity and regulatory support before brand adoption. The ingredient type is projected to capture 41.0% share in 2026. 21st.BIO states that its programs include dairy proteins such as beta-lactoglobulin and caseins. [2]

Which customer type dominates?

Fermentation-Based Food and Ingredient Brands lead because most lack owned manufacturing assets.

Fermentation-Based Food and Ingredient Brands lead because many companies own strains, IP and formulations but not production-scale bioreactors. Liberation Bioindustries announced in 2025 that it would produce Vivici’s Vivitein™ BLG at commercial scale from its Richmond, Indiana precision fermentation facility, which has 600,000 liters of capacity and a dedicated downstream process [3]. They need CDMOs to reduce capital burden and shorten launch timelines. This customer type is likely to account for 46.0% share in 2026.

Which delivery model dominates?

Capacity Reservation and Toll Manufacturing lead because brands need secured production slots.

Capacity Reservation and Toll Manufacturing lead because ingredient brands must guarantee scale-up capacity before signing commercial supply or food brand agreements. The model is projected to hold 39.0% share in 2026. This model leads because production availability is now a strategic launch risk.

Which end use dominates?

Animal-Free Dairy Ingredients hold 37.0% share in 2026.

Animal-Free Dairy Ingredients lead because dairy proteins create clear use cases in cheese and nutritional products. DairyX stated in 2024 that its precision-fermented casein proteins can self-assemble into micelles, which are primary building blocks of dairy products such as cheese and yogurt [4]. The end use is expected to hold 37.0% share in 2026. Dairy ingredient applications lead because functionality can be demonstrated directly in familiar foods.

What is accelerating precision fermentation CDMO services demand, and what is holding it back?

Capacity shortage and downstream processing complexity drive demand; high capital intensity restrains adoption.

Capacity shortage is the main driver of demand for precision fermentation CDMO services. Liberation Bioindustries stated in 2025 that well over 50% of nameplate capacity at its Richmond plant was under contract or in late-stage agreements, showing strong customer demand for available commercial fermentation capacity [5]. This shows that food and ingredient companies are looking for available fermentation capacity before building their own production assets.

The main restraint is capital intensity. Commercial precision fermentation facilities require expensive bioreactors and food-grade quality systems. Many CDMOs also need customer commitments before building capacity. Service providers must balance flexible access with plant utilization before the business model can scale profitably.

Where do the biggest precision fermentation CDMO service opportunities sit?

Commercial manufacturing and dairy-protein scale-up.

• Commercial Manufacturing: CDMOs can sell food-grade production access to brands without bioreactors.
• Downstream Processing: Providers can reduce cost through purification and formulation support.
• Dairy-Protein Scale-Up: Service firms can support beta-lactoglobulin, casein and other animal-free dairy ingredients.

Which countries are scaling precision fermentation CDMO services fastest?

United States 42.2%, Denmark 40.6%, Switzerland 39.4%, Belgium 37.8%, South Korea 36.7%.

Based on regional analysis, the precision fermentation CDMO services market is segmented into North America, Western Europe, East Asia, Asia Pacific, Latin America, and Middle East and Africa.

What is powering the United States lead?

The United States is projected to record 42.2% CAGR through 2036 as commercial-scale food fermentation capacity comes online. The country has a strong base of fermentation startups and food brands seeking domestic capacity. CDMO demand will focus on pilot-to-commercial transfer and downstream processing. Service providers with available capacity will gain stronger access to dairy protein and specialty ingredient programs.

How is Denmark scaling precision fermentation CDMO demand?

Denmark benefits from industrial fermentation know-how and 21st.BIO’s strain-to-scale model. The country is expected to post 40.6% CAGR through 2036. 21st. Danish demand will focus on process development and technology transfer. Providers that connect strain engineering with industrial production design will be better placed.

What underpins Switzerland’s growth?

Switzerland is likely to record 39.4% CAGR through 2036 as Planetary-style fermentation platforms support European ingredient brands. Swiss demand will focus on full-stack platform services and cost optimization. Food ingredient firms need partners that can scale fermentation without owning factories. Growth will favor providers that combine process optimization and sustainability-focused production planning.

What supports Belgium’s outlook?

Belgium is forecast to advance at 37.8% CAGR through 2036 as BioBrew uses AB InBev fermentation and downstream processing expertise. Belgium’s brewing and biotech ecosystem supports food-grade fermentation services. Demand will favor providers that can convert beverage fermentation know-how into protein and ingredient production.

How is South Korea scaling precision fermentation CDMO services?

South Korea is set to record 36.7% CAGR through 2036 as CJ CheilJedang’s fermentation base supports food and nutrition ingredient scale-up. South Korean demand will focus on food additives and fermentation-derived functional components. Ingredient brands will need partners with quality systems and high-volume manufacturing capability. Service growth will favor companies with proven fermentation operations and global food customer access.

Who leads the precision fermentation CDMO services landscape?

Liberation Bioindustries and Planetary lead through commercial capacity and full-stack fermentation platforms.

Precision fermentation CDMO services are used by food ingredient brands and biotechnology companies that need outsourced manufacturing. Liberation Bioindustries, formerly Liberation Labs, is building commercial-scale precision fermentation capacity through its Richmond facility. 21st.BIO supports strain development and regulatory services.

Planetary provides a full-stack fermentation platform for production at scale. BioBrew applies AB InBev’s scaled fermentation and downstream processing expertise to precision fermentation. CJ CheilJedang supports fermentation-derived food and nutrition ingredients through its CJ BIO platform. Competition through 2036 will depend on available capacity and production economics.

Providers that combine scale-up with downstream processing will be better placed. Pilot-stage specialists can win early development programs. Commercial CDMOs can win capacity-reservation contracts. Large fermentation incumbents can gain by converting existing know-how into food-grade precision fermentation services.

Which companies are the key players?

Liberation Bioindustries, 21st.BIO, Planetary, BioBrew and CJ BIO / CJ CheilJedang.

• Liberation Bioindustries
• 21st.BIO
• Planetary
• BioBrew (AB InBev)
• CJ BIO / CJ CheilJedang

Bibliography

• [1] Liberation Bioindustries. (2025, December 18). Liberation Bioindustries named one of “26 Food-Techs to Watch in 2026” by Protein Production Technology International.
• [2] Pinon, M. (2024, May 6). 21st.BIO unveils a new pilot plant facility to accelerate impact of biotech innovations globally. 21st.BIO.
• [3] Vivici. (2025, May 8). Powering active lifestyles: Vivici and Liberation Bioindustries bring the new standard of protein to the U.S.
• [4] Robinson, N. (2024, September 25). Cow-less casein protein “first” creates full cheese spectrum. FoodNavigator.

This Report Addresses

• Strategic intelligence on precision fermentation CDMO services across service type, ingredient type and customer type.
• Segment analysis covering Food-Grade Contract Manufacturing, Dairy Proteins, Fermentation-Based Food and Ingredient Brands, Capacity Reservation and Animal-Free Dairy Ingredients.
• Regional outlook covering the United States, Denmark, Switzerland, Belgium and South Korea.
• Competitive analysis of Liberation Bioindustries, 21st.BIO, Planetary, BioBrew and CJ BIO / CJ CheilJedang.
• Service assessment covering scale-up, contract manufacturing, downstream processing and quality support.
• Ingredient assessment covering dairy proteins, specialty fats, collagen alternatives, enzymes and nutrition ingredients.
• Primary interviews, provider checks, official source review and CDMO capacity validation support the forecast.

What does the precision fermentation CDMO services market cover?

Contract development and manufacturing services for precision-fermented food ingredients.

The precision fermentation CDMO services market covers outsourced services that help food and ingredient companies develop and manufacture precision-fermented proteins and functional ingredients. It includes strain-to-scale process support and quality documentation. The market differs from precision fermentation ingredient markets because the focus is outsourced production services.

What is included in the scope?

Scale-up and quality support.

The scope includes process development and technology transfer. It covers food-grade contract manufacturing and formulation support. It includes quality systems and ingredient launch readiness. It also includes commercial production partnerships for brands that do not own fermentation facilities.

What is excluded from the scope?

Ingredient sales without outsourced development or manufacturing services.

The scope excludes branded precision-fermented ingredients sold directly by producers unless CDMO services are offered. It excludes pharmaceutical biologics CDMO services with no food ingredient application. It excludes fermentation equipment sales without contract manufacturing or process services. It also excludes standard brewery operations unless precision fermentation food or ingredient production is supported.

How was the analysis built?

100+ sources, 40+ company portfolios, 25+ countries, 20+ interviews.

• Primary Research:
  • Primary research includes interviews with fermentation ingredient startups and scale-up engineers. It includes input from CDMO operators and downstream processing specialists.
• Desk Research:
  • Desk research reviews official CDMO service pages and commercial fermentation announcements. It covers food-grade capacity and biomanufacturing service models.
• Market-Sizing and Forecasting:
  • Forecasting uses fermentation-based food company counts and production-stage conversion. Capacity expansion and downstream processing intensity support the market assessment.
• Data Validation and Update Cycle:
  • Forecasts are validated through provider checks and ingredient company feedback. Facility start-up timelines and capacity disclosures help confirm market direction.